大洋生物 (003017)
ZHEJIANG DAYANG BIOTECH GROUP CO.,LTD.
K-Line Chart
No K-line data available
Company NameZhejiang Dayang Biotechnology Group Co., Ltd.
Listing Date2020-10-26
Issue Price28.85RMB
Registered Capital840010k RMB
Legal RepresentativeChen Yanggui
Registered AddressNo. 22 Chaoyang Road, Dayang Town, Jiande City, Hangzhou, Zhejiang Province, China
IndustryChemical Raw Materials
Main BusinessProduction and sales of chemical raw material products such as inorganic salts and veterinary APIs.
Company ProfileThe company is a National High-Tech Enterprise, an "Honoring Contracts and Valuing Credit" enterprise certified by the State Administration for Industry and Commerce, a Zhejiang Provincial Patent Demonstration Enterprise, and a Zhejiang Provincial Green Enterprise. It has passed ISO9001, ISO14001, ISO22000, and OHSAS18001 international system certifications. Dayang Bio has established a comprehensive innovation management system, including a provincial-level R&D center and an enterprise research institute, relying on technological progress to obtain numerous patents and proprietary technologies. By implementing strategies of branding, automation, informatization, and internationalization, Dayang Bio continuously meets the needs of human production and life through its global operational network, high-quality products, and professional services. Dayang Bio focuses on three core industries: potassium salts, veterinary drugs, and fluorine chemical engineering. It has formed a product portfolio led by potassium carbonate, potassium bicarbonate, and ammonium chloride, with multi-specification series development for food-grade, industrial-grade, and agricultural-grade applications. The highly effective anticoccidial drug Amprolium Hydrochloride has passed US FDA certification and veterinary drug GMP system certification. To meet different market requirements for Amprolium Hydrochloride, a series of products with high fluidity, high quality, and low impurities have been developed, making it a superior brand with refined advantages. Fluorine-containing products are mainly led by 2-Chloro-6-fluorobenzaldehyde, while also producing series such as 2-Chloro-6-fluorobenzoic acid and 2-Chloro-6-fluorobenzyl chloride.
Stock Details
1. Key Indicators
- Total Shares(W): 8400.00
- Circulating A-Shares(W): 6928.80
- Earnings Per Share(RMB): 0.9846
- Net Assets Per Share(RMB): 13.0651
- Operating Revenue(W RMB): 74730.54
- Total Profit(W RMB): 8208.04
- Net Profit Attributable to Parent(W RMB): 8003.66
- Net Profit Growth Rate(%): 56.12
- Weighted Return on Equity(%): 7.4200
- Operating Cash Flow Per Share(RMB): 1.3550
- Undistributed Profit Per Share(RMB): 5.2397
- Capital Reserve Per Share(RMB): 6.4924
2. Main Business
The main business covers:
- Manufacturing and sales of basic chemical raw materials
- Manufacturing and sales of chemical products
3. Company Basic Information
- Company Name: Zhejiang Dayang Biotech Group Co., Ltd.
- Listing Date: 2020-10-26
- Industry: Manufacturing of Chemical Raw Materials and Chemical Products
- Address: No. 22 Chaoyang Road, Dayang Town, Jiande City, Hangzhou, Zhejiang Province, China
- Website: www.dyhg.com
- Company Profile: The company, formerly known as Zhejiang Dayang Chemical Co., Ltd., was established in December 2009 through the overall restructuring of Dayang Co., Ltd. It is primarily engaged in the manufacturing and sales of basic chemical raw materials and chemical products.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Dayang Biotech Group Co., Ltd.-2024 Employee Stock Ownership Plan | Asset Management Plan | 99.20 | 1.43 |
| 2 | Penghua Stable Return Hybrid Securities Investment Fund A Class | Fund | 47.16 | 0.68 |
5. Concept Sectors
- Chip
- Fluorine Concept
- China-Russia Trade
- Fertilizer Concept
- PEEK Material
- Micro-Cap Stocks
- High-Performance Stocks
- Fund Exclusive
- Being Acquired
- Dispersed Ownership
- Decreasing Shareholder Number
- Intended Reduction
- Small-Cap Non-Financing
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information